JCS
Jcurve Solutions Ltd
🇦🇺 ASX
🤖 TECHNOLOGY
👑 Overview
📈 Performance
💰 Dividends
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-4.67%
Annual Growth
5 years average annual growth
💰
4.07%
Annual dividend yield
Based on the most recent dividend
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
1
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
JCurve Solutions Ltd. engages in the business of developing software applications and solutions for corporate and government industries. The company is headquartered in Chatswood, New South Wales. The company went IPO on 2000-12-08. The firm is engaged in the sale, implementation and support of Enterprise Resource Planning (ERP) solutions, which consist of the exclusively licensed small business edition of Oracle NetSuite, JCurve ERP (in Australia and New Zealand), and the Oracle NetSuite mid-market and enterprise editions. Its segments include ANZ ERP, Asia ERP, TEMS and Quicta. ANZ ERP segment includes ERP cloud-based Business Management solutions and associated consulting services that are sold to Australian and New Zealand customers. Asia ERP segment includes ERP cloud-based Business Management solutions and associated consulting services, which are sold to Southeast Asian customers. TEMS segment develops and markets Telecommunications Expense Management Solutions (JTEL, Full Circle and Phoneware) that are sold to Australian customers. Quicta segment develops and sells service management and scheduling software.
📈 Performance
Price History
-28.13%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💰 Dividends
Payouts
💰 Annual Dividend Yield*
4.07%
💰 Annual Dividend Earnings Per $1,000 invested**
$40.70
💰 Most Recent Dividend Franked Percentage Estimate
100.00%
💰 Average Dividend Franked Percentage Estimate
100.00 %
💰 Dividend reinvestment
* Based on the most recent dividend
** Calculated by multiplying the most recent dividend yield by $1,000
Estimate your dividend
If you held
$
of JCS, your last dividend payment(s) would have been:
$ 581.4
on Tue Sep 05 2023
*Disclaimer: The information provided in this calculator is only a model to show you how long you need to invest for to achieve your goal, based on several factors, including past performance which is not an indicator of future performance. It is not a prediction and relies on assumptions, such as interest rates, that may vary and change the actual outcome. The results shown are only estimates and are not intended to be relied on when making a financial decision. Consider whether to get advice from a licensed financial adviser before making any financial decision.
Dividend History
1Y
5Y
10Y
Graph
Table
Year
Yearly Dividend Earnings Per Share
Franking Estimate
2024
$0.00
0.00%
2023
$0.00
100.00%
2022
$0.00
0.00%
2021
$0.00
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
2015
$0.00
0.00%
💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.02
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in JCS
1
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
85 weeks
💵 Average investment amount
$291
⏰ Last time a customer invested in JCS
1133 days
JCS investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
100%
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
100%
🙋 Legal gender of investors
Female
Male
100%
Pearlers who invest in JCS also invest in...
Pharmaxis Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. The company is headquartered in Frenchs Forest, New South Wales. The company went IPO on 2003-11-10. The firm has a productive drug discovery engine and drug candidates in clinical trials. Its drug candidate, PXS-5505, is an orally taken drug that inhibits the lysyl oxidase family of enzymes. PXS-5505 is used for the treatment of the blood cancer myelofibrosis. PXS-5505 is also being investigated as a potential treatment for other cancers, such as liver and pancreatic cancer. Its other drugs in development include PXS-5382 (LOXL2 inhibitor), PXS-6302 (topical pan LOX inhibitor), PXS-4728 (SSAO inhibitor), PXS-4699 (dual SSAO/MAOB inhibitor) and PXS-5370 (dual SSAO/MPO inhibitor). Its drug candidates developed from the pipeline targets diseases where inflammatory and fibrotic processes play a significant role, which include pulmonary fibrosis, chronic kidney disease, NASH, Parkinson's disease and cardiac fibrosis.
🙌 Performance (5Yr p.a)
-17.96%
📊 Share price
$0.03 AUD
NULL PHARMACEUTICALS
Rex Minerals Ltd. engages in the exploration and development of mineral properties. The firm's projects include Hillside Project and Hog Ranch Project. The Hillside Project is located 165 kilometers (kms) from Adelaide and 12 km south of the Ardrossan township on the Yorke Peninsula, South Australia. The Hillside Project is an iron oxide copper gold (IOCG) deposit, under shallow cover, in the Gawler Craton, which collectively hosts the largest copper producing projects in Australia. The Hillside Project has a resource that contains approximately 1.9 Mt of copper (Cu) and 1.5 million ounces (Moz) of gold (Au) and is one of the most significant projects in Australia. The Hog Ranch Gold Property is located in Washoe County in north-west Nevada, approximately 45 km from the California border and 91 km from the Oregon border. The Hog Ranch Gold Property has a Joint Ore Reserve Committee (JORC) compliant Mineral Resource of approximately 2.2 Moz gold.
🙌 Performance (5Yr p.a)
74.85%
📊 Share price
$0.46 AUD
⛏️ MINING
KYP
Kinatico Ltd. engages in the provision of screening and verification services. The company is headquartered in Perth, Western Australia. The company went IPO on 2015-09-08. The Company’s solutions comprise pre-employment screening, verification services and workforce compliance management internationally. The company provides real-time workforce compliance management via its core software-as-a-service RegTech solution Cited. By combining certifications and compliance data with business policy and legislative requirements, Cited enables scalable compliance monitoring spanning pre-employment to real-time requirements related to geo-location, roles and tasks applicable across a range of industries. The company also provides a range of pre-employment checks via its CVCheck solution. This is delivered via its technology platform, which include employment screening and verification offering. Its OnCite is a native mobile application available in iOS and Android, that allows workers to manage their own compliance daily, control their own credentials, and share that information.
🙌 Performance (5Yr p.a)
-3.93%
📊 Share price
$0.11 AUD
🤖 TECHNOLOGY
Syntara Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. The company is headquartered in Frenchs Forest, New South Wales. The company went IPO on 2003-11-10. The Company’s highly productive drug discovery engine is driven by its expertise in amine oxidase inhibitors. Its lead candidate, PXS-5505, is used for the bone marrow cancer myelofibrosis, which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The firm is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its PXS-4728 is a SSAO/MAOB inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis, and cardiac fibrosis. The company has developed two respiratory products: Bronchitol, for cystic fibrosis, and Aridol, a lung function test.
🙌 Performance (5Yr p.a)
-16.95%
📊 Share price
$0.03 AUD
🕊️ SOCIALLY AWARE
📦 LOGISTICS
Want more shares? Try these...
Judo Capital Holdings Ltd. provides financial services to small and medium enterprises. The company is headquartered in Melbourne, Victoria and currently employs 543 full-time employees. The company went IPO on 2021-11-01. Judo Bank offers term deposits directly and via intermediaries to a range of deposit customers including individuals, charities, universities, government bodies, self-managed super funds (SMSFs) and corporates. All deposits are term deposits, with limited overlap between the small and medium enterprises (SMEs) lending customers and deposit customer base. The firm provides business lending solutions to SMEs. The company also offers business loans, lone of credit, equipment loan, and bank guarantee services. . Its other subsidiaries include Judo Securitisation Warehouse Trust 2020 - 1, Judo Securitisation Trust 2020 - 2, Judo Securitisation Trust 1R, Judo Capital Holdings Limited Employee Share Trust, Judo Securitisation Trust 2022 - 1, Judo Securitisation Trust 2023 - 1, Judo Securitisation Trust 2023 - 2, and Judo Capital Markets Trust 2023 - 1.
📊 Share price
$1.75 AUD
🏦 BANKING
Judo Capital Holdings Ltd. provides financial services to small and medium enterprises. The company is headquartered in Melbourne, Victoria and currently employs 543 full-time employees. The company went IPO on 2021-11-01. Judo Bank offers term deposits directly and via intermediaries to a range of deposit customers including individuals, charities, universities, government bodies, self-managed super funds (SMSFs) and corporates. All deposits are term deposits, with limited overlap between the small and medium enterprises (SMEs) lending customers and deposit customer base. The firm provides business lending solutions to SMEs. The company also offers business loans, lone of credit, equipment loan, and bank guarantee services. . Its other subsidiaries include Judo Securitisation Warehouse Trust 2020 - 1, Judo Securitisation Trust 2020 - 2, Judo Securitisation Trust 1R, Judo Capital Holdings Limited Employee Share Trust, Judo Securitisation Trust 2022 - 1, Judo Securitisation Trust 2023 - 1, Judo Securitisation Trust 2023 - 2, and Judo Capital Markets Trust 2023 - 1.
📊 Share price
$111.79 AUD
🏦 BANKING
JB Hi-Fi Ltd. engages in the retail of home consumer products from stand-alone destination sites, shopping center locations, and online stores. The company is headquartered in Southbank, Victoria and currently employs 14,500 full-time employees. The company went IPO on 2003-10-23. The company offers a range of brands with a particular focus on consumer electronics, software (including music, games, and movies), whitegoods and appliances. The company operates through three segments: JB Hi-Fi Australia (JB Aust), JB Hi-Fi New Zealand (JB NZ) and The Good Guys (TGG). The firm comprises two retail brands: JB Hi-Fi and The Good Guys. JB Hi-Fi is a retailer of technology and consumer electronics with a position with a young tech-savvy demographic. The Good Guys is a retailer of home appliances and consumer electronics with a position with home-making families. The company has multichannel sales capability with sales primarily from its branded retail store networks (JB Hi-Fi/JB Hi-Fi Home stores in Australia, JB Hi-Fi stores in New Zealand and The Good Guys stores in Australia), online operations (JB Hi-Fi and The Good Guys websites) and over the phone. The company also provides information technology and consulting services.
🙌 Performance (5Yr p.a)
25.22%
📊 Share price
$78.81 AUD
📈 HIGH PRICE GROWTH
🛍️ CONSUMER
💰 HIGH DIVIDEND
James Bay Minerals Ltd. operates as a mineral and exploration company. The company is headquartered in Perth, Western Australia. The company went IPO on 2023-09-12. The Company, through its wholly owned subsidiary, holds a 100% interest in 573 claims comprising the La Grande Project, La Grande East and the Troilus Project in Quebec, Canada (Projects), with the La Grande Project consisting of the Joule, Aero, and Aqua Properties. The Joule Property is its flagship asset, covering an area of about 16,385 hectares (ha) along the Robert-Bourassa reservoir. The Aero Property consists of about 101 continuous claims covering an area of 4,980 ha. The Aqua Property consists of about 172 continuous claims covering an area of 8,803 ha and increased by 109 claims and 56 square kilometers. Its La Grande East Project is situated approximately 15 kilometers (km) from its Aqua Property and includes 136 claims, covering an area of 7,000 ha along the Robert-Bourassa reservoir. The Troilus Project is located further to the south, sitting only five km to the north of Sayona’s Moblan Lithium Project.
📊 Share price
$0.14 AUD
⛏️ MINING